Generic (brand) Therapeutic Class --> MOA

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/98

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 11:19 PM on 6/23/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

99 Terms

1
New cards

buprenorphine/naloxone (Suboxone, Zubsolv)

Opioid Partial Agonist/Antagonist --> Partial mu-opioid agonist and opioid antagonist

2
New cards

carisoprodol (Soma, Vanadom)

Centrally Acting Skeletal Muscle Relaxant --> Blocks interneuronal activity in reticular formation and spinal cord

3
New cards

celecoxib (Celebrex, Elyxyb)

COX-2 Inhibitor --> Selectively inhibits cyclooxygenase-2, reducing prostaglandin synthesis

4
New cards

codeine (Tylenol with Codeine)

Opioid Analgesic --> Weak mu-opioid receptor agonist

5
New cards

cyclobenzaprine (Flexeril)

Centrally Acting Skeletal Muscle Relaxant --> Reduces tonic somatic motor activity via brainstem action

6
New cards

diclofenac (Cambia, Voltaren, Zipsor, Zorvolex)

NSAID --> Nonselective COX-1 and COX-2 inhibitor

7
New cards

fentanyl (Duragesic)

Opioid Analgesic --> Potent mu-opioid receptor agonist

8
New cards

hydrocortisone

Topical Corticosteroid --> Induces lipocortins that inhibit phospholipase A2

9
New cards

ibuprofen (Motrin, Advil)

NSAID --> Reversible nonselective COX-1 and COX-2 inhibitor

10
New cards

indomethacin (Indocin, Tivorbex)

NSAID --> Reversible nonselective COX-1 and COX-2 inhibitor

11
New cards

lidocaine patch (Lidoderm, Lidotral)

Local Anesthetic --> Blocks sodium channels, stabilizing neuronal membranes

12
New cards

meloxicam (Mobic)

NSAID --> Preferential COX-2 inhibition, reducing prostaglandin synthesis

13
New cards

methadone (Dolophine)

Opioid Analgesic --> Mu-opioid receptor agonist

14
New cards

methocarbamol (Robaxin, Tanlor)

Centrally Acting Skeletal Muscle Relaxant --> CNS depression leading to muscle relaxation

15
New cards

morphine (MS Contin, Avinza, Kadian)

Opioid Analgesic --> Pure mu-opioid receptor agonist

16
New cards

naproxen (Naprosyn, Naprelan)

NSAID --> Reversible nonselective COX-1 and COX-2 inhibitor

17
New cards

oxycodone (OxyContin, Roxicodone)

Opioid Analgesic --> Pure mu-opioid receptor agonist

18
New cards

pentosan (Elmiron)

Urinary Analgesic --> Adheres to bladder mucosa forming protective barrier

19
New cards

sumatriptan (Imitrex, Onzetra, Sumavel, Tosymra, Zembrace)

Antimigraine Serotonin Agonist --> 5-HT1 receptor agonist causing cranial vasoconstriction

20
New cards

tramadol (ConZip, Ultram, Qdolo)

Opioid Analgesic --> Weak mu-opioid agonist and serotonin/norepinephrine reuptake inhibitor

21
New cards

acyclovir (Zovirax)

Viral DNA Polymerase Inhibitor --> Converted to acyclovir triphosphate, inhibits viral DNA polymerase

22
New cards

albendazole (Albenza)

Anthelmintic --> Inhibits microtubule formation and glucose uptake in parasites

23
New cards

amoxicillin/clavulanate (Augmentin)

Beta-Lactam Antibiotic --> Amoxicillin inhibits bacterial cell wall synthesis; clavulanate inhibits beta-lactamases

24
New cards

amoxicillin (Amoxil, Moxatag)

Beta-Lactam Antibiotic --> Inhibits bacterial cell wall synthesis by binding PBPs

25
New cards

atazanavir (Reyataz)

Protease Inhibitor --> Inhibits HIV protease preventing maturation of viral particles

26
New cards

azithromycin (Zithromax, Z-Pak)

Macrolide Antibiotic --> Binds 50S ribosomal subunit inhibiting protein synthesis

27
New cards

baricitinib (Olumiant)

JAK Inhibitor --> Inhibits Janus kinase signaling pathways involved in inflammation

28
New cards

cefdinir (Omnicef)

3rd Generation Cephalosporin --> Inhibits bacterial cell wall synthesis by binding PBPs

29
New cards

cefuroxime (Ceftin, Zinacef)

2nd Generation Cephalosporin --> Inhibits bacterial cell wall synthesis by binding PBPs

30
New cards

cephalexin (Keflex, Daxbia)

1st Generation Cephalosporin --> Inhibits bacterial cell wall synthesis by binding PBPs

31
New cards

chlorhexidine (Peridex, Paroex, Hibiclens, Periogard)

Antibacterial Cleansing Agent --> Disrupts bacterial cell membranes causing cell death

32
New cards

ciprofloxacin (Cipro, Cipro XR)

Fluoroquinolone Antibiotic --> Inhibits DNA gyrase and topoisomerase IV

33
New cards

clarithromycin (Biaxin)

Macrolide Antibiotic --> Binds 50S ribosomal subunit inhibiting protein synthesis

34
New cards

clindamycin (Cleocin)

Lincosamide Antibiotic --> Binds 50S ribosomal subunit inhibiting protein synthesis

35
New cards

doxycycline (Vibramycin, Doxy 100)

Tetracycline Antibiotic --> Binds 30S ribosomal subunit inhibiting protein synthesis

36
New cards

efavirenz (Sustiva)

NNRTI --> Inhibits HIV reverse transcriptase

37
New cards

elbasvir/grazoprevir (Zepatier)

Hepatitis C Antiviral --> Elbasvir inhibits NS5A; grazoprevir inhibits NS3/4A protease

38
New cards

emtricitabine/tenofovir (Truvada)

NRTI Antiretroviral --> Inhibits HIV reverse transcriptase causing chain termination

39
New cards

entecavir (Baraclude)

Antiviral --> Inhibits hepatitis B viral polymerase

40
New cards

erythromycin (Erythrocin)

Macrolide Antibiotic --> Binds 50S ribosomal subunit inhibiting protein synthesis

41
New cards

fidaxomicin (Dificid)

Macrolide Antibiotic --> Inhibits bacterial RNA polymerase, primarily against C. difficile

42
New cards

fluconazole (Diflucan)

Azole Antifungal --> Inhibits fungal ergosterol synthesis

43
New cards

gatifloxacin (Zymaxid)

Fluoroquinolone Antibiotic --> Inhibits DNA gyrase and topoisomerase IV

44
New cards

glecaprevir/pibrentasvir (Mavyret)

Hepatitis C Antiviral --> Glecaprevir inhibits NS3/4A protease; pibrentasvir inhibits NS5A

45
New cards

hydroxychloroquine (Plaquenil, Sovuna)

Aminoquinolone --> Interferes with lysosomal activity and immune signaling

46
New cards

imiquimod (Zyclara)

Immune Response Modifier --> Activates Toll-like receptor 7 increasing cytokine production

47
New cards

ketoconazole (Nizoral, Ketodan)

Azole Antifungal --> Inhibits fungal ergosterol synthesis

48
New cards

levofloxacin (Levaquin)

Fluoroquinolone Antibiotic --> Inhibits DNA gyrase and topoisomerase IV

49
New cards

maraviroc (Selzentry)

CCR5 Antagonist --> Blocks CCR5 receptor preventing HIV entry

50
New cards

metronidazole (Flagyl, Likmez)

Nitroimidazole Antibiotic --> Forms toxic free radicals that damage microbial DNA

51
New cards

minocycline (Minocin, Emrosi)

Tetracycline Antibiotic --> Binds 30S ribosomal subunit inhibiting protein synthesis

52
New cards

moxifloxacin (Vigamox, Moxeza, Avelox)

Fluoroquinolone Antibiotic --> Inhibits DNA gyrase and topoisomerase IV

53
New cards

mupirocin (Bactroban)

Topical Antibacterial --> Inhibits bacterial isoleucyl-tRNA synthetase

54
New cards

nirmatrelvir/ritonavir (Paxlovid)

Protease Inhibitor --> Nirmatrelvir inhibits SARS-CoV-2 protease; ritonavir boosts levels

55
New cards

nitazoxanide (Alinia)

Antiprotozoal --> Interferes with anaerobic energy metabolism

56
New cards

nitrofurantoin (Macrobid)

Nitrofuran Antibiotic --> Damages bacterial DNA and ribosomal proteins

57
New cards

nystatin (Bio-Statin, Mycostatin, Nyamyc, Nystop)

Polyene Antifungal --> Binds ergosterol causing fungal membrane leakage

58
New cards

oseltamivir (Tamiflu)

Neuraminidase Inhibitor --> Inhibits influenza neuraminidase preventing viral release

59
New cards

penicillin

Beta-Lactam Antibiotic --> Inhibits bacterial cell wall synthesis by binding PBPs

60
New cards

polymyxin B/trimethoprim (Polytrim)

Ophthalmic Antibiotic --> Disrupts bacterial membranes and inhibits folate synthesis

61
New cards

raltegravir (Isentress)

Integrase Inhibitor --> Inhibits HIV integrase preventing viral DNA integration

62
New cards

sofosbuvir (Sovaldi)

HCV Polymerase Inhibitor --> Inhibits NS5B RNA-dependent RNA polymerase

63
New cards

trimethoprim/sulfamethoxazole (Bactrim)

Sulfonamide Antibiotic --> Sequential blockade of bacterial folate synthesis

64
New cards

valacyclovir (Valtrex)

Viral DNA Polymerase Inhibitor --> Converted to acyclovir, inhibits viral DNA polymerase

65
New cards

darifenacin (Enablex)

Urinary Antispasmodic, Selective M3 Antagonist --> Competitively blocks M3 muscarinic receptors in the bladder

66
New cards

dexlansoprazole (Dexilant)

Proton Pump Inhibitor (PPI) --> Irreversibly inhibits gastric H+/K+ ATPase proton pumps

67
New cards

diphenoxylate/atropine (Lomotil)

Antidiarrheal --> Slows GI motility through opioid receptor activation

68
New cards

esomeprazole (Nexium)

Proton Pump Inhibitor (PPI) --> Irreversibly inhibits gastric H+/K+ ATPase proton pumps

69
New cards

famotidine (Pepcid)

H2 Receptor Antagonist --> Competitively blocks histamine H2 receptors on parietal cells

70
New cards

finasteride (Proscar, Propecia)

5-Alpha Reductase Inhibitor --> Prevents conversion of testosterone to dihydrotestosterone (DHT)

71
New cards

lansoprazole (Prevacid)

Proton Pump Inhibitor (PPI) --> Irreversibly inhibits gastric H+/K+ ATPase proton pumps

72
New cards

linaclotide (Linzess)

Guanylate Cyclase-C Agonist --> Increases intestinal chloride and bicarbonate secretion

73
New cards

lubiprostone (Amitiza)

Chloride Channel Activator --> Activates chloride channels increasing intestinal fluid secretion

74
New cards

metoclopramide (Reglan, Gimoti)

Dopamine Antagonist / Prokinetic --> Blocks dopamine receptors and enhances GI motility

75
New cards

omeprazole (Prilosec)

Proton Pump Inhibitor (PPI) --> Irreversibly inhibits gastric H+/K+ ATPase proton pumps

76
New cards

ondansetron (Zofran)

Antiemetic --> Selectively blocks 5-HT3 serotonin receptors

77
New cards

pantoprazole (Protonix)

Proton Pump Inhibitor (PPI) --> Irreversibly inhibits gastric H+/K+ ATPase proton pumps

78
New cards

phenazopyridine (Pyridium)

Urinary Tract Analgesic --> Local analgesic effect on urinary tract mucosa

79
New cards

polyethylene glycol (Miralax, GoLYTELY, NuLYTELY, MoviPrep, Plenvu)

Hyperosmotic Laxative --> Retains water in intestinal lumen by osmotic action

80
New cards

rabeprazole (AcipHex)

Proton Pump Inhibitor (PPI) --> Irreversibly inhibits gastric H+/K+ ATPase proton pumps

81
New cards

rifaximin (Xifaxan)

Miscellaneous Antibiotic --> Inhibits bacterial DNA-dependent RNA polymerase

82
New cards

sucralfate (Carafate)

GI Protectant --> Forms protective barrier over ulcer sites

83
New cards

tamsulosin (Flomax)

Alpha-1 Adrenergic Blocker --> Relaxes smooth muscle of prostate and bladder neck

84
New cards

tizanidine (Zanaflex)

Alpha-2 Adrenergic Agonist Muscle Relaxant --> Increases presynaptic inhibition of motor neurons

85
New cards

albuterol (ProAir, Proventil, Ventolin)

Selective Beta-2 Agonist --> Stimulates beta-2 receptors causing bronchodilation

86
New cards

budesonide/formoterol (Symbicort, Breyna)

ICS/LABA Combination --> Budesonide reduces airway inflammation; formoterol stimulates beta-2 receptors causing bronchodilation

87
New cards

budesonide (Pulmicort)

Inhaled Corticosteroid --> Suppresses inflammatory mediator production

88
New cards

cetirizine (Zyrtec)

2nd Generation Antihistamine --> Selectively blocks peripheral H1 receptors

89
New cards

fexofenadine (Allegra)

2nd Generation Antihistamine --> Selectively blocks peripheral H1 receptors

90
New cards

fluticasone nasal (Flonase, Xhance)

Nasal Corticosteroid --> Inhibits inflammatory mediator release

91
New cards

fluticasone inhaled (ArmonAir, Arnuity Ellipta, Flovent Diskus)

Inhaled Corticosteroid --> Glucocorticoid receptor agonist reducing airway inflammation

92
New cards

fluticasone/salmeterol (Advair, AirDuo, Wixela)

ICS/LABA Combination --> Fluticasone suppresses inflammation; salmeterol stimulates beta-2 receptors causing bronchodilation

93
New cards

hydroxyzine (Atarax, Vistaril)

1st Generation Antihistamine --> Blocks H1 receptors and depresses CNS activity

94
New cards

ipratropium/albuterol (Combivent)

SAMA/SABA Combination --> Ipratropium blocks muscarinic receptors; albuterol stimulates beta-2 receptors

95
New cards

levalbuterol (Xopenex)

Selective Beta-2 Agonist --> Stimulates beta-2 receptors causing bronchodilation

96
New cards

mometasone nasal (Nasonex)

Nasal Corticosteroid --> Inhibits inflammatory mediator release

97
New cards

mometasone inhaled (Asmanex)

Inhaled Corticosteroid --> Suppresses airway inflammation through glucocorticoid receptor activation

98
New cards

montelukast (Singulair)

Leukotriene Receptor Antagonist --> Blocks leukotriene receptors reducing bronchoconstriction and inflammation

99
New cards

tiotropium (Spiriva)

Long-Acting Muscarinic Antagonist (LAMA) --> Blocks M3 receptors causing bronchodilation